Inventor · disambiguated record
Weiguang Zeng
Also filed as: ZENG WEIGUANG
13 granted patents·9 pending applications·71 citations·filing 2002–2024
91Inventor score
Files withJACKSON DAVID CHARLES4QUEENSLAND INST MED RES4Axelia Oncology Pty Ltd3Ena Therapeutics Pty Ltd3UNIV MELBOURNE3
Top patents by PatentIndex Score
22 records- 0189US12017979B2MoleculesEna Respiratory Pty Ltd·Filed 2023·Granted Jun 25, 2024·2 cites·4 claims
- 0289US8986700B2Immunogenic lipopeptides comprising T-helper and cytotoxic T-lymphocyte (CTL) epitopesJACKSON DAVID·Filed 2010·Granted Mar 24, 2015·9 cites·18 claims
- 0387US11786458B2Immunostimulatory methodEna Respiratory Pty Ltd·Filed 2022·Granted Oct 17, 2023·1 cites·24 claims
- 0486US11351114B2Immunostimulatory methodEna Therapeutics Pty Ltd·Filed 2019·Granted Jun 7, 2022·3 cites·25 claims
- 0584US8367067B2Immunogenic lipopeptides comprising T-helper and B-cell epitopesQUEENSLAND INST MED RES·Filed 2009·Granted Feb 5, 2013·7 cites·13 claims
- 0684US7569225B2Immunogenic lipopeptides comprising T-helper and B-cell epitopesQUEENSLAND INST MED RES·Filed 2003·Granted Aug 4, 2009·21 cites·11 claims
- 0783US9089508B2Method of transfection and compositions thereforJACKSON DAVID CHARLES·Filed 2008·Granted Jul 28, 2015·11 cites·23 claims
- 0882US9889195B2Immunogenic composition and uses thereofUNIV MELBOURNE·Filed 2015·Granted Feb 13, 2018·3 cites·3 claims
- 0979US10406100B2Immunostimulatory methodEna Therapeutics Pty Ltd·Filed 2017·Granted Sep 10, 2019·3 cites·13 claims
- 1076US12195557B2Optimised compoundsAxelia Oncology Pty Ltd·Filed 2018·Granted Jan 14, 2025·1 cites·5 claims
- 1175US9676819B2Immunostimulatory methodJACKSON DAVID CHARLES·Filed 2011·Granted Jun 13, 2017·3 cites·28 claims
- 1273US2025066416A1Optimised compoundsAxelia Oncology Pty Ltd·Filed 2024·Application pending·0 cites
- 1372US7833532B2Immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopesQUEENSLAND INST MED RES·Filed 2003·Granted Nov 16, 2010·6 cites·32 claims
- 1462US9340622B2Synthetic immunogen useful for generating long lasting immunity and protection against pathogensAGREWALA JAVED N·Filed 2011·Granted May 17, 2016·1 cites·14 claims
- 1555US2022388950A1Novel moleculesAxelia Oncology Pty Ltd·Filed 2020·Application pending·0 cites
- 1651US2012064109A1Immunogenic composition and uses thereofJACKSON DAVID CHARLES·Filed 2011·Application pending·0 cites
- 1751US2011262473A1Synthetic vaccine componentUNIV MELBOURNE·Filed 2009·Application pending·0 cites
- 1850US2010266623A1Synthetic, self adjuvanting vaccinesUNIV MELBOURNE·Filed 2009·Application pending·0 cites
- 1944US2002169264A1Polymers incorporating peptidesQUEENSLAND INST MED RES·Filed 2002·Application pending·0 cites
- 2040US2010129385A1Immunogenic moleculesJACKSON DAVID C·Filed 2006·Application pending·0 cites
- 2139US2009105155A1Truncated lhrh formulationsJACKSON DAVID CHARLES·Filed 2005·Application pending·0 cites
- 2237US2020147028A1Treatment of respiratory infection with a tlr2 agonistEna Therapeutics Pty Ltd·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Weiguang Zeng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →